24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Securities
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
11:37
Intel and Weizmann researchers unveil breakthrough to make AI models run faster
22:00
Decart launches real-time AI tool for live video transformation
21:27
Full list of Israeli high-tech layoffs in 2025
21:24
$205M-backed TytoCare cuts 20% of staff, CEO Gilad to transition to chairman role
More stories
Buzz
Most popular
Daily
Weekly
1
Israel orders more Arrow 3 missiles, rushes Arrow 4 to meet hypersonic threats
2
Oracle CEO: "Some of the best people in the world are here in Israel, and there's no question about that"
3
AT&T buys $650M stake in DriveNets, delivering major payout to founders, employees and early backers
4
Mapping Israel’s $20B GenAI boom: 342 startups and counting
5
Underground mapping startup Exodigo raises $96M, hits $700M valuation
More news
Securities
2 stories about Securities
Israeli Regulator to Mutual Fund Managers: Don't Invest in Bitcoin Futures
12.12.17
|
Raheli Bindman
Global bitcoin futures opened for trading for the first time this week, sending enthusiasts into an investment frenzy
Allergan Planning Sale of its Teva Stock
01.11.17
|
Dror Reich and Lilach Baumer
For the third quarter of 2017, Allergan reported an operating loss of $4.02 billion, $1.3 billion of which is due to the depreciation of its Teva securities.
Previous Articles
